Acne: Asthma Drug Fails to Help Patients with Acne

Word Count:
245

Summary:
The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.

Keywords:
acne treatments

Article Body:
The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.

*****************************************************

Recommended For You

Facebook Remarketing 2019-20 Success Kit PLR

Get this Up-to-date "Facebook Remarketing 2019-20 Success Kit" with PLR Rights and start cashing in huge by selling it as your own.

Tuberank Jeet 4 Pro Trial

With the help of Tuberank Jeet 4 you can easily drive traffic on your Youtube channels, that will improve your rankings and will also maintain them. If all your traffic is coming from Facebook and Google then this is what you need. It will get you titles,

*****************************************************

Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos – far short of achieving statistical significance.

Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.

The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.

Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent “proof of concept” trial.

The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.

Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO).

It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.

*************************************************** 

This is a PLR article. We recommend to re write the article before re use it.

 We use : Spin Rewriter

Spin Rewriter Will Give You Unlimited Free High Quality Content... No Copyscape issues. No duplicate content penalty. Completely readable. FREE of charge. Without any work. All thanks to Spin Rewriter.

 
Thank you for taking the time to read our article.

If you enjoyed our content, we'd really appreciate some "love" with a share or two.

And ... Don't forget to have fun!

Recommended

Stockocity 4K Pro 4000 Add'l 3840x2160 Stock Videos Developer License

Stockocity 4K Pro - 4000 additional 3840x2160 fully licensed stock videos with Developer License.

Instagram Marketing 2018 Success Kit PLR

Get this Up-to-date "Instagram Marketing 2018 Success Kit" with PLR Rights and start cashing in huge by selling it as your own.